微信关注
Total item
Cart Subtotal
￥ 0.00 Epigenetics
-
Delgocitinib
Catalog No. A19234 JAK inhibitorDelgocitinib is a novel and specific JAK inhibitor with IC50s of 2.8, 2.6, 13 and 58 nM for JAK1, JAK2, JAK3 and Tyk2, respectively. 了解更多 -
Gusacitinib
Catalog No. A19883 SYK/JAK inhibitorGusacitinib (ASN-002) is a potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 values of 5-46 nM. 了解更多 -
TG-02 (SB1317)
Catalog No. A11962 -
CHZ868
Catalog No. A15937 -
SB1317 (TG02)
Catalog No. A13454 CDK/JAK2/FLT3 抑制剂SB1317是细胞周期蛋白依赖性激酶（CDKs）、类FMS酪氨酸激酶-3（FLT3）和Janus激酶2（JAK2）的有效抑制剂，CDK2、JAK2和FLT3的IC50值分别为13nM、56nM和73nM。 了解更多 -
PF-06651600
Catalog No. A16803 JAK3 抑制剂PF-06651600是一种有效且不可逆的JAK3选择性抑制剂，IC50为33.1 nM，但对JAK1，JAK2和TYK2没有活性（IC50> 10 000 nM）。 了解更多 -
Ruxolitinib Phosphate
Catalog No. A11552 JAK 抑制剂Ruxolitinib Phosphate是ruxolitinib的磷酸盐形式，ruxolitinib是一种口服生物可利用的Janus相关激酶(JAK)抑制剂，具有潜在的抗肿瘤和免疫调节活性。 了解更多 -
PF-06700841 tosylate
Catalog No. A17176 -
JAK3-IN-2
Catalog No. A18323 JAK3 抑制剂JAK3-IN-2 is a potent and highly selective JAK3 inhibitor with IC50 of 0.15 nM. dispalys >4,300-fold selectivity over JAK1, JAK2 and TYK2, and other kinases BMX, EGFR, ITK and BTK; blocks cytokine signaling through JAK3, but not through other JAK family enzymes; inhibits IL-7 induced pSTAT5 in CD3+, CD8+ T cells with IC50 of 280 nM; sufficiently blocks the development of inflammation in a rat model of rheumatoid arthritis, while sparing hematopoiesis. 了解更多 -
Abrocitinib (PF-04965842)
Catalog No. A18318 JAK1 抑制剂Abrocitinib (PF-04965842) is a potent, orally active and selective JAK1 inhibitor, with IC50s of 29 and 803 nM for JAK1 and JAK2, respectively. Abrocitinib (PF-04965842) exhibits less active effect on TYK2 (IC50, 1.253 μM), and inhibits phosphorylation of STAT1, STAT3 and STAT5 after stimulation. Effective in autoimmune disease. 了解更多 -
Upadacitinib (ABT-494)
Catalog No. A18316 JAK-1 抑制剂Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor being developed for the treatment of several autoimmune disorders with an IC50 of 43 nM. IC50 & Target: IC50: 43 nM (JAK1), 200 nM (JAK2) 了解更多 -
BMS-986165
Catalog No. A18726 TYK2 抑制剂BMS-986165 is a Highly Potent and Selective Allosteric Inhibitor of TYK2. BMS-986165 Blocks Il-12, IL-23 and type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Inflammatory Bowel Disease. 了解更多 -
JAK3 covalent inhibitor-1
Catalog No. A18926 JAK3 covalent 抑制剂JAK3 covalent inhibitor-1 is a potent and selective janus kinase 3 (JAK3) covalent inhibitor with an IC50 of 11 nM and shows 246-fold selectivity vs other JAKs. 了解更多 -
Tofacitinib
Catalog No. A17252 JAK3/2/1 inhibitorTofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively. 了解更多 -
PF-06263276
Catalog No. A12572 pan-JAK inhibitorPF-06263276 (PF 6263276) is a potent and selective pan-JAK inhibitor, with IC50s of 2.2 nM, 23.1 nM, 59.9 nM and 29.7 nM for JAK1, JAK2, JAK3 and TYK2, respectively. 了解更多 -
Ruxolitinib sulfate
Catalog No. A11467 JAK1/2 inhibitorRuxolitinib sulfate (INCB018424 sulfate) is the first potent, selective JAK1/2 inhibitor to enter the clinic with IC50s of 3.3 nM/2.8 nM, and has > 130-fold selectivity for JAK1/2 versus JAK3. 了解更多 -
Oclacitinib maleate
Catalog No. A16640 JAK inhibitorOclacitinib maleate (PF-03394197 maleate) is a novel JAK inhibitor. Oclacitinib maleate (PF-03394197 maleate) is most potent at inhibiting JAK1 (IC50=10 nM). 了解更多 -
NVP-BSK805 dihydrochloride
Catalog No. A21406 JAK2 inhibitorNVP-BSK805 dihydrochloride (BSK805 dihydrochloride) is an ATP-competitive JAK2 inhibitor, with IC50s of 0.48 nM, 31.63 nM, 18.68 nM, and 10.76 nM for JAK2 JH1 (JAK homology 1), JAK1 JH1, JAK3 JH1, and TYK2 JH1, respectively. 了解更多 -
PF-06700841 P-Tosylate
Catalog No. A21652 dual JAK1/TYK2 inhibitorPF-06700841 P-Tosylate is a potent dual Janus kinase 1 (JAK1) and TYK2 inhibitor with IC50s of 17 nM and 23 nM, respectively. 了解更多 -
Momelotinib Mesylate
Catalog No. A21658 JAK1/JAK2 inhibitorMomelotinib Mesylate (CYT387 Mesylate) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, appr 10-fold selectivity versus JAK3. 了解更多 -
SGI-1776 (free base)
Catalog No. A10838 PIM1 抑制剂SGI-1776 (free base)是Pim1的一种新型ATP竞争性抑制剂，在无细胞试验中的IC50为7 nM，选择性是Pim2和Pim3的50倍和10倍，对Flt3和haspin也有效。阶段1。 了解更多 -
(Z)-SMI-4a
Catalog No. A11945 Pim 抑制剂SIM-4a是一种Pim激酶抑制剂，可通过激活AMPK来阻断mTORC1的活性。 通常对Pim-2有效，不会显着抑制任何其他丝氨酸/苏氨酸或酪氨酸激酶。 了解更多 -
TCS PIM-1 4a (SMI-4a)
Catalog No. A11967 Pim 抑制剂TCS PIM-1 4a (SMI-4a)是一种具有选择性和ATP竞争性的Pim激酶抑制剂（Pim-1和Pim-2的IC50值分别为24和100 nM）。 了解更多 -
CX-6258 HCl
Catalog No. A14275 Pan-PIM kinase 抑制剂CX-6258 HCl是一种有效的口服泛Pim激酶抑制剂，对Pim1，Pim2和Pim3的IC50为5 nM，25 nM和16 nM。 了解更多 -
LGB-321 HCl
Catalog No. A14420 Pan-PIM kinase 抑制剂LGB-321 HCl是一种有效且选择性的PIM激酶竞争性小分子抑制剂（Pan-PIM激酶抑制剂）。 了解更多 -
CX-6258 hydrochloride hydrate
Catalog No. A15055 Pim 抑制剂CX-6258 hydrochloride hydrate是一种有效的，口服有效的Pim 1/2/3激酶（IC50 = 5 nM/25 nM/16 nM）抑制剂，具有出色的生化效能和激酶选择性。 了解更多 -
PIM-1 Inhibitor 2
Catalog No. A15368 -
TCS PIM-1 1
Catalog No. A15369 Pim-1 Kinase 抑制剂TCS PIM-1 1是一种有效的且具有选择性的ATP竞争性Pim-1 kianse抑制剂，IC50为50 nM，对Pim-2和MEK1/MEK2表现出良好的选择性（IC50s> 20,000 nM）。 了解更多 -
PIM447 (LGH447)
Catalog No. A16807 Pim 抑制剂PIM447 (LGH447)是一种新型的pan-PIM激酶抑制剂，其PIM1，PIM2，PIM3的Ki值分别为6 pM，18 pM，9 pM。它也抑制GSK3β，PKN1和PKCτ，但效力显着降低，IC50在1-5μM之间（相对于PIM上Ki的差异> 105倍）。 了解更多 -
AZD1208 HCl
Catalog No. A16927 -
-
最新产品
SMI-16a
Catalog No. A17157 -
FILTER BY:
购物选项
- 分类
-
- HDAC (102)
- PARP (49)
- JAK (87)
- Pim (18)
- Aurora Kinase (37)
- Sirtuins (30)
- Epigenetic Reader Domain (81)
- Histone Demethylases (29)
- DNA Methyltransferases (14)
- Histone Acetyltransferases (22)
- Histone Methyltransferase (64)
- Protein Arginine Methyltransferases (12)
- Protein serine/threonine phosphatase (7)
- Protein Tyrosine Phosphatase (10)
- 作用机制
-
- Inhibitor (抑制剂) (474)
- Agonist (激动剂) (1)
- Antagonist (拮抗剂) (8)
- Activator (激活剂) (12)
- Modulator (调节剂) (1)
- Blocker (阻断剂) (1)
- Degrader (降解剂) (8)
- Inducer (诱导剂) (1)
- Substrate (底物) (1)
- 靶点
-
- 2OG oxygenases (2)
- A3 adenosine receptor (1)
- Abl (3)
- Aurora A (27)
- Aurora B (22)
- Aurora C (11)
- BAZ2A (2)
- BAZ2B (2)
- Bcr-Abl (1)
- BET (5)
- BRD2 (7)
- BRD3 (4)
- BRD4 (9)
- BRD7 (1)
- BRD9 (4)
- BRPF1 (4)
- BRPF2 (1)
- CDK (3)
- CDK4 (1)
- CECR2 (1)
- COMT (1)
- CYP3A4 (1)
- DNMT (7)
- DNMT1 (1)
- DNMT3A (1)
- DNMT3B (2)
- DOT1L (3)
- EGFR (3)
- ErbB2 (1)
- EZH1 (1)
- EZH2 (14)
- FAK (1)
- FGFR1 (3)
- FGFR2 (1)
- FGFR3 (1)
- FLT3 (9)
- G9a (EHMT2) (10)
- GLP (EHMT1) (5)
- HAT (1)
- HD1 (2)
- HD2 (1)
- HDAC (21)
- HDAC1 (24)
- HDAC10 (4)
- HDAC11 (4)
- HDAC2 (15)
- HDAC3 (19)
- HDAC4 (6)
- HDAC5 (4)
- HDAC6 (23)
- HDAC7 (2)
- HDAC8 (9)
- HDAC9 (3)
- HER2 (1)
- IGF1R (1)
- JAK1 (18)
- JAK2 (38)
- JAK3 (17)
- Jumonji histone demethylase (1)
- KAT5 (Tip60) (3)
- KDM1A (LSD1) (8)
- KDM2 (1)
- KDM4 (JMJD2) (1)
- KDM5 (JARID1) (4)
- KDM6A (UTX) (2)
- KDM6B (JMJD3) (2)
- KDM7 (1)
- L3MBTL (2)
- L3MBTL1 (1)
- Lck (1)
- MAO-A (1)
- MAO-B (1)
- Mdm2 (1)
- MEK1 (2)
- MEK2 (1)
- Menin-MLL interaction (2)
- MGMT (2)
- MLL1 (1)
- Mnk1 (1)
- Mnk2 (1)
- NAT10 (1)
- NF-κB (1)
- p110α (1)
- p110β (1)
- p110γ (1)
- p110δ (1)
- p300/CBP (7)
- p53 (2)
- PARP (13)
- PARP1 (10)
- PARP2 (4)
- PCAF (1)
- PDE3 (1)
- PDE5 (1)
- Pim1 (9)
- Pim2 (7)
- Pim3 (5)
- PKCα (1)
- PKCβ (1)
- PRMT1 (4)
- PRMT3 (2)
- PRMT5 (2)
- PRMT6 (1)
- RET (2)
- SETD7 (1)
- SETD8 (1)
- SIRT1 (6)
- SIRT2 (5)
- SIRT3 (1)
- Sirtuin (1)
- SMARCA4 (1)
- SMYD2 (2)
- SMYD3 (2)
- Src (3)
- STAT1 (1)
- STAT3 (3)
- STAT5 (1)
- SUV39H (1)
- Syk (2)
- TAF1 (1)
- Tankyrase-1 (5)
- Tankyrase-2 (8)
- TrkA (2)
- Tyk2 (5)
- VEGFR2 (FLK1) (1)
- WDR5 (1)
ADOOQ 产品质量保证
We promise all products to perform as described.